174 related articles for article (PubMed ID: 38625512)
1. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J
Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512
[TBL] [Abstract][Full Text] [Related]
2. Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
Matsumori Y; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Takeshima T; Hirata K
Neurol Ther; 2022 Mar; 11(1):205-222. PubMed ID: 34862581
[TBL] [Abstract][Full Text] [Related]
3. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S
J Headache Pain; 2023 Jul; 24(1):88. PubMed ID: 37460942
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
[TBL] [Abstract][Full Text] [Related]
5. Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study.
Pascual J; Núñez M; Panni T; Díaz-Cerezo S; Novick D; Ciudad A
Pain Ther; 2023 Oct; 12(5):1209-1220. PubMed ID: 37458965
[TBL] [Abstract][Full Text] [Related]
6. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
[TBL] [Abstract][Full Text] [Related]
8. The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
Schwedt TJ; Digre K; Tepper SJ; Spare NM; Ailani J; Birlea M; Burish M; Mechtler L; Gottschalk C; Quinn AM; McGillicuddy L; Bance L; Dumkrieger G; Chong CD; Dodick DW
Headache; 2020 Feb; 60(2):337-347. PubMed ID: 31755111
[TBL] [Abstract][Full Text] [Related]
9. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
Hirata K; Komori M; Ueda K; Zagar AJ; Kim Y; Jaffe DH; Matsumori Y; Takeshima T
Drugs Real World Outcomes; 2023 Sep; 10(3):415-428. PubMed ID: 37278957
[TBL] [Abstract][Full Text] [Related]
11. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for acute attacks of vestibular migraine.
Webster KE; Dor A; Galbraith K; Haj Kassem L; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD015322. PubMed ID: 37042545
[TBL] [Abstract][Full Text] [Related]
13. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
Kawata AK; Shah N; Poon JL; Shaffer S; Sapra S; Wilcox TK; Shah S; Tepper SJ; Dodick DW; Lipton RB
Headache; 2021 Mar; 61(3):438-454. PubMed ID: 33594686
[TBL] [Abstract][Full Text] [Related]
14. Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study.
Lipton RB; Buse DC; Dodick DW; Schwedt TJ; Singh P; Munjal S; Fanning K; Bostic Bs R; Reed ML
Headache; 2021 Jan; 61(1):103-116. PubMed ID: 33326608
[TBL] [Abstract][Full Text] [Related]
15. Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS).
Dissing AS; Lee XY; Østerberg O; Hammer-Helmich L
Neurol Ther; 2023 Dec; 12(6):2053-2065. PubMed ID: 37728666
[TBL] [Abstract][Full Text] [Related]
16. Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study.
Takeshima T; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Matsumori Y; Hirata K
Adv Ther; 2022 Nov; 39(11):5176-5190. PubMed ID: 36089637
[TBL] [Abstract][Full Text] [Related]
17. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
[TBL] [Abstract][Full Text] [Related]
18. Identifying the factors underlying discontinuation of triptans.
Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
[TBL] [Abstract][Full Text] [Related]
19. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844
[TBL] [Abstract][Full Text] [Related]
20. Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) Study.
Shapiro RE; Nicholson RA; Seng EK; Buse DC; Reed ML; Zagar AJ; Ashina S; Muenzel EJ; Hutchinson S; Pearlman EM; Lipton RB
Neurology; 2024 Feb; 102(3):e208074. PubMed ID: 38232340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
